Parabilis Medicines, Inc. (PBLS)
Market Closed
15 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
25. 18
-0.71
-2.7424%
$
3.2B Market Cap
- P/E Ratio
- Div Yield
954,610 Volume
- Eps
$ 25.89
Previous Close 
Want to track PBLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Parabilis Medicines, Inc. (PBLS) Statistics
Valuation metrics
Market Cap 3.2B
Enterprise value 2.16B
Trailing P/E (ttm) -0.74
Forward P/E -
PEG ratio 0.11
Price/Sales (ttm) 21,643.21
Price/Book (mrq) 0.76
Enterprise Value/Revenue 14,619.23
Enterprise Value/EBITDA -22.52
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.09M
Average volume (90 days) 549.51K
Price summary
52-Week low 20
52-Week high 42.49
Beta -
50-Day moving average 34.18
200-Day moving average 28.75
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -660.67%
Operating margin -664.45%
Operational effectiveness
Return on assets -0.08%
Return on equity -0.15%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.38
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 38.77
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 17.91%
Book value per share (mrq) 36.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
